Royal Bank of Canada
CCRN

Royal Bank of Canada’s Cross Country Healthcare CCRN Stock Holding History

Royal Bank of Canada’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$459K Buy
48,851
+14,950
+44% +$134K ﹤0.01% 4212
2025
Q4 		$274K Sell
33,901
-23,317
-41% -$255K ﹤0.01% 4563
2025
Q3 		$812K Sell
57,218
-4,711
-8% -$62.2K ﹤0.01% 4136
2025
Q2 		$808K Buy
61,929
+59,825
+2,843% +$822K ﹤0.01% 4081
2025
Q1 		$31K Sell
2,104
-48,375
-96% -$831K ﹤0.01% 5755
2024
Q4 		$916K Sell
50,479
-30,700
-38% -$413K ﹤0.01% 3607
2024
Q3 		$1.09M Buy
81,179
+71,192
+713% +$1.05M ﹤0.01% 3477
2024
Q2 		$138K Sell
9,987
-25,096
-72% -$397K ﹤0.01% 5053
2024
Q1 		$656K Sell
35,083
-1,578
-4% -$31.6K ﹤0.01% 3778
2023
Q4 		$830K Sell
36,661
-45,315
-55% -$983K ﹤0.01% 3807
2023
Q3 		$2.03M Sell
81,976
-51,419
-39% -$1.29M ﹤0.01% 2830
2023
Q2 		$3.75M Sell
133,395
-11,242
-8% -$279K ﹤0.01% 2319
2023
Q1 		$3.23M Buy
144,637
+8,211
+6% +$215K ﹤0.01% 2431
2022
Q4 		$3.63M Buy
136,426
+38,686
+40% +$1.26M ﹤0.01% 2385
2022
Q3 		$2.77M Buy
97,740
+50,639
+108% +$1.3M ﹤0.01% 2549
2022
Q2 		$981K Buy
47,101
+44,798
+1,945% +$839K ﹤0.01% 3530
2022
Q1 		$50K Sell
2,303
-5,413
-70% -$117K ﹤0.01% 6098
2021
Q4 		$214K Sell
7,716
-2,247
-23% -$54.5K ﹤0.01% 5275
2021
Q3 		$211K Buy
9,963
+1,103
+12% +$20.7K ﹤0.01% 5122
2021
Q2 		$147K Buy
8,860
+4,574
+107% +$69.8K ﹤0.01% 5326
2021
Q1 		$53K Sell
4,286
-11,957
-74% -$127K ﹤0.01% 5842
2020
Q4 		$144K Sell
16,243
-75
-0.5% -$610 ﹤0.01% 5097
2020
Q3 		$105K Sell
16,318
-874
-5% -$5.54K ﹤0.01% 4946
2020
Q2 		$105K Sell
17,192
-25
-0.1% -$153 ﹤0.01% 4824
2020
Q1 		$116K Buy
17,217
+9,639
+127% +$91.3K ﹤0.01% 4684
2019
Q4 		$88K Buy
7,578
+1,153
+18% +$13K ﹤0.01% 5152
2019
Q3 		$66K Sell
6,425
-37
-0.6% -$364 ﹤0.01% 5005
2019
Q2 		$61K Sell
6,462
-1,081
-14% -$8.32K ﹤0.01% 5158
2019
Q1 		$53K Buy
7,543
+693
+10% +$5.94K ﹤0.01% 5126
2018
Q4 		$51K Sell
6,850
-1,712
-20% -$14.3K ﹤0.01% 5091
2018
Q3 		$75K Buy
8,562
+1,770
+26% +$18.1K ﹤0.01% 5027
2018
Q2 		$76K Buy
6,792
+492
+8% +$5.87K ﹤0.01% 4962
2018
Q1 		$70K Hold
6,300
– – ﹤0.01% 4883
2017
Q4 		$81K Sell
6,300
-732,020
-99% -$9.67M ﹤0.01% 4927
2017
Q3 		$10.5M Buy
738,320
+29,674
+4% +$372K 0.01% 1508
2017
Q2 		$9.15M Buy
708,646
+137,788
+24% +$1.78M ﹤0.01% 1558
2017
Q1 		$8.2M Buy
570,858
+80,718
+16% +$1.19M ﹤0.01% 1597
2016
Q4 		$7.65M Sell
490,140
-193,698
-28% -$2.65M ﹤0.01% 1674
2016
Q3 		$8.05M Sell
683,838
-31,619
-4% -$416K ﹤0.01% 1626
2016
Q2 		$9.96M Buy
715,457
+328,838
+85% +$4.36M 0.01% 1463
2016
Q1 		$4.5M Buy
386,619
+192,886
+100% +$2.45M ﹤0.01% 1888
2015
Q4 		$3.18M Buy
193,733
+177,547
+1,097% +$2.82M ﹤0.01% 2181
2015
Q3 		$220K Buy
16,186
+4,356
+37% +$59.2K ﹤0.01% 4242
2015
Q2 		$150K Buy
11,830
+1,530
+15% +$17.3K ﹤0.01% 4573
2015
Q1 		$122K Sell
10,300
-270
-3% -$3.09K ﹤0.01% 4507
2014
Q4 		$132K Sell
10,570
-10,730
-50% -$110K ﹤0.01% 4592
2014
Q3 		$198K Hold
21,300
– – ﹤0.01% 4196
2014
Q2 		$139K Hold
21,300
– – ﹤0.01% 4383
2014
Q1 		$172K Hold
21,300
– – ﹤0.01% 4224
2013
Q4 		$213K Sell
21,300
-24,700
-54% -$171K ﹤0.01% 4112
2013
Q3 		$278K Sell
46,000
-400
-0.9% -$2.29K ﹤0.01% 3837
2013
Q2 		$239K Buy
+46,400
New +$238K ﹤0.01% 3755

Other funds holding CCRN

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Royal Bank of Canada's CCRN Position: Q1 2026 in Review

Royal Bank of Canada increased its Cross Country Healthcare (CCRN) stake by 44% in Q1 2026, buying an estimated $134K and bringing the position to 48,851 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #4212.

Royal Bank of Canada first reported a position in CCRN in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.5M in Q3 2017. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Royal Bank of Canada held 48,851 shares of Cross Country Healthcare worth $459K as of Q1 2026.
  • Royal Bank of Canada bought 14,950 Cross Country Healthcare shares in Q1 2026, an estimated $134K.
  • Cross Country Healthcare made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4212 holding.
  • Royal Bank of Canada first reported a position in Cross Country Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Cross Country Healthcare position peaked at $10.5M in Q3 2017.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.